BRPI1007653A2 - "dispositivos para inalação de insumos medicinais e componentes dos mesmos" - Google Patents

"dispositivos para inalação de insumos medicinais e componentes dos mesmos"

Info

Publication number
BRPI1007653A2
BRPI1007653A2 BRPI1007653A BRPI1007653A BRPI1007653A2 BR PI1007653 A2 BRPI1007653 A2 BR PI1007653A2 BR PI1007653 A BRPI1007653 A BR PI1007653A BR PI1007653 A BRPI1007653 A BR PI1007653A BR PI1007653 A2 BRPI1007653 A2 BR PI1007653A2
Authority
BR
Brazil
Prior art keywords
inhalation
devices
components
medicinal products
medicinal
Prior art date
Application number
BRPI1007653A
Other languages
English (en)
Inventor
A Kelly Jean
M David Moses
A Jinks Philip
Iyer Suresh
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Publication of BRPI1007653A2 publication Critical patent/BRPI1007653A2/pt

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05DPROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D5/00Processes for applying liquids or other fluent materials to surfaces to obtain special surface effects, finishes or structures
    • B05D5/08Processes for applying liquids or other fluent materials to surfaces to obtain special surface effects, finishes or structures to obtain an anti-friction or anti-adhesive surface
    • B05D5/083Processes for applying liquids or other fluent materials to surfaces to obtain special surface effects, finishes or structures to obtain an anti-friction or anti-adhesive surface involving the use of fluoropolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00Containers or packages with special means for dispensing contents
    • B65D83/14Containers for dispensing liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant
    • B65D83/38Details of the container body
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/002Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from unsaturated compounds
    • C08G65/005Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from unsaturated compounds containing halogens
    • C08G65/007Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from unsaturated compounds containing halogens containing fluorine
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • C08G65/336Polymers modified by chemical after-treatment with organic compounds containing silicon
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D183/00Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon, with or without sulfur, nitrogen, oxygen, or carbon only; Coating compositions based on derivatives of such polymers
    • C09D183/10Block or graft copolymers containing polysiloxane sequences
    • C09D183/12Block or graft copolymers containing polysiloxane sequences containing polyether sequences
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/009Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/02General characteristics of the apparatus characterised by a particular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/02General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0222Materials for reducing friction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/02General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0238General characteristics of the apparatus characterised by a particular materials the material being a coating or protective layer
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05DPROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D1/00Processes for applying liquids or other fluent materials
    • B05D1/34Applying different liquids or other fluent materials simultaneously
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05DPROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D2350/00Pretreatment of the substrate
    • B05D2350/60Adding a layer before coating
    • B05D2350/63Adding a layer before coating ceramic layer
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05DPROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D3/00Pretreatment of surfaces to which liquids or other fluent materials are to be applied; After-treatment of applied coatings, e.g. intermediate treating of an applied coating preparatory to subsequent applications of liquids or other fluent materials
    • B05D3/14Pretreatment of surfaces to which liquids or other fluent materials are to be applied; After-treatment of applied coatings, e.g. intermediate treating of an applied coating preparatory to subsequent applications of liquids or other fluent materials by electrical means
    • B05D3/141Plasma treatment
    • B05D3/142Pretreatment
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04Polysiloxanes
    • C08G77/22Polysiloxanes containing silicon bound to organic groups containing atoms other than carbon, hydrogen and oxygen
    • C08G77/24Polysiloxanes containing silicon bound to organic groups containing atoms other than carbon, hydrogen and oxygen halogen-containing groups
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/42Block-or graft-polymers containing polysiloxane sequences
    • C08G77/46Block-or graft-polymers containing polysiloxane sequences containing polyether sequences

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Materials Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Medicinal Preparation (AREA)
  • Polyethers (AREA)
BRPI1007653A 2009-05-06 2010-05-06 "dispositivos para inalação de insumos medicinais e componentes dos mesmos" BRPI1007653A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17589809P 2009-05-06 2009-05-06
PCT/US2010/033853 WO2010129758A1 (en) 2009-05-06 2010-05-06 Medicinal inhalation devices and components thereof

Publications (1)

Publication Number Publication Date
BRPI1007653A2 true BRPI1007653A2 (pt) 2019-09-24

Family

ID=42361780

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1007653A BRPI1007653A2 (pt) 2009-05-06 2010-05-06 "dispositivos para inalação de insumos medicinais e componentes dos mesmos"

Country Status (7)

Country Link
US (1) US20120097159A1 (pt)
EP (1) EP2427278B1 (pt)
CN (1) CN102458690B (pt)
AU (1) AU2010245839B2 (pt)
BR (1) BRPI1007653A2 (pt)
CA (1) CA2760808A1 (pt)
WO (1) WO2010129758A1 (pt)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0721737D0 (en) * 2007-11-06 2007-12-19 3M Innovative Properties Co Medicinal inhalation devices and components thereof
EP2427902B1 (en) 2009-05-06 2017-01-18 3M Innovative Properties Company Apparatus and method for plasma treatment of containers
WO2010129753A1 (en) 2009-05-06 2010-11-11 3M Innovative Properties Company Medicinal inhalation device
US8664323B2 (en) * 2010-06-25 2014-03-04 3M Innovative Properties Company Fluorinated composition, method of coating the composition, and article thereby
FR2979214B1 (fr) * 2011-08-26 2014-04-25 Seb Sa Article comportant un revetement antiadhesif presentant des proprietes ameliorees d'adherence au support
CN107540242B (zh) * 2012-02-28 2020-11-20 康宁股份有限公司 具有低摩擦涂层的玻璃制品
US11497681B2 (en) 2012-02-28 2022-11-15 Corning Incorporated Glass articles with low-friction coatings
US10737973B2 (en) 2012-02-28 2020-08-11 Corning Incorporated Pharmaceutical glass coating for achieving particle reduction
RU2674269C2 (ru) 2012-06-07 2018-12-06 Корнинг Инкорпорейтед Стойкие к расслаиванию стеклянные контейнеры
US10273048B2 (en) 2012-06-07 2019-04-30 Corning Incorporated Delamination resistant glass containers with heat-tolerant coatings
US9034442B2 (en) * 2012-11-30 2015-05-19 Corning Incorporated Strengthened borosilicate glass containers with improved damage tolerance
GB201221063D0 (en) 2012-11-23 2013-01-09 3M Innovative Properties Co Metered dose dispensing valve
US10117806B2 (en) * 2012-11-30 2018-11-06 Corning Incorporated Strengthened glass containers resistant to delamination and damage
US9027877B1 (en) * 2014-04-10 2015-05-12 Google Inc. Filling apparatus for high-altitude balloons
AU2015264249A1 (en) 2014-05-22 2016-12-08 3M Innovative Properties Company Coating process
RU2691189C2 (ru) 2014-09-05 2019-06-11 Корнинг Инкорпорейтед Стеклянные изделия и способы повышения надежности стеклянных изделий
EP3206998B1 (en) 2014-11-26 2021-09-08 Corning Incorporated Methods for producing strengthened and durable glass containers
EP3150564B1 (en) 2015-09-30 2018-12-05 Corning Incorporated Halogenated polyimide siloxane chemical compositions and glass articles with halogenated polylmide siloxane low-friction coatings
WO2017075018A1 (en) 2015-10-29 2017-05-04 3M Innovative Properties Company Formulation and aerosol canisters, inhalers, and the like containing the formulation
US20170121058A1 (en) 2015-10-30 2017-05-04 Corning Incorporated Glass articles with mixed polymer and metal oxide coatings
US11207477B2 (en) 2017-05-17 2021-12-28 Kindeva Drug Delivery L.P. Formulation and aerosol canisters, inhalers, and the like containing the formulation
WO2019025994A2 (en) 2017-08-03 2019-02-07 3M Innovative Properties Company COATING PROCESS
WO2019088129A1 (ja) * 2017-10-31 2019-05-09 ダイキン工業株式会社 硬化性組成物
EP3705530A4 (en) * 2017-10-31 2021-08-25 Daikin Industries, Ltd. CURING COMPOSITION
FR3077013B1 (fr) * 2018-01-24 2023-12-15 Aptar France Sas Dispositif de distribution de produit fluide.
WO2019236649A1 (en) 2018-06-07 2019-12-12 3M Innovative Properties Company Fluticasone and vilanterol formulation and inhaler
EP3801456A1 (en) 2018-06-07 2021-04-14 Kindeva Drug Delivery L.P. Fluticasone and vilanterol formulation and inhaler
CN112262172B (zh) 2018-06-12 2023-08-01 3M创新有限公司 包含胺固化剂的含氟聚合物涂料组合物、经涂覆的基底以及相关方法
WO2019239320A1 (en) 2018-06-12 2019-12-19 3M Innovative Properties Company Fluoropolymer compositions comprising fluorinated additives, coated substrates and methods
WO2020006017A1 (en) 2018-06-27 2020-01-02 3M Innovative Properties Company Tiotropium formulation and inhaler
US20210393598A1 (en) 2018-11-12 2021-12-23 Kindeva Drug Delivery L.P. Umeclidinium and vilanterol formulation and inhaler
WO2021088198A1 (en) 2019-11-04 2021-05-14 3M Innovative Properties Company Electronic telecommunications articles comprising crosslinked fluoropolymers and methods
EP4055109A1 (en) 2019-11-04 2022-09-14 3M Innovative Properties Company Fluoropolymer compositions comprising a curing agent with ethylenically unsaturated and electron donor groups, and substrates coated therewith
WO2022051645A2 (en) 2020-09-04 2022-03-10 Corning Incorporated Ultraviolet light-blocking coated pharmaceutical packages
US20250009653A1 (en) 2021-09-08 2025-01-09 Kindeva Drug Delivery L.P. Propellants for anticholinergic agents in pressurized metered dose inhalers
JP2026509779A (ja) 2022-03-01 2026-03-25 キンデーバ ドラッグ デリバリー リミティド パートナーシップ 定量吸入器及び高用量懸濁液
EP4402192B1 (en) * 2022-08-18 2025-07-02 10X Genomics, Inc. Droplet forming devices and methods having flourous diol additives
AU2024230006A1 (en) 2023-03-02 2025-09-18 Kindeva Drug Delivery L.P. Metered dose inhalers and solutions including cannabinoids in hfa-152a
EP4673113A1 (en) 2023-03-02 2026-01-07 Kindeva Drug Delivery L.P. Metered dose inhalers and solutions including cannabinoids in hfo-1234ze(e)

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3646085A (en) * 1970-09-24 1972-02-29 Du Pont Perfluoroalkyletheramidoalkyltrialkoxysilanes
US6596260B1 (en) 1993-08-27 2003-07-22 Novartis Corporation Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
TR199701169T1 (xx) 1995-04-14 1998-03-21 Glaxo Wellcome Inc. Salmeterol i�in �l��lm�� doz inhaleri.
HU219899B (hu) 1995-04-14 2001-09-28 Glaxo Wellcome Inc. Inhalálóberendezés flutikaszon-propionát adagolására mért dózisban
TR199701170T1 (xx) 1995-04-14 1998-02-21 Glaxo Wellcome Inc. Beklometazon dipropionat i�in �l��lm�� doz inhaleri.
HU219900B (hu) 1995-04-14 2001-09-28 Glaxo Wellcome Inc. Mért dózist adagoló inhalálóberendezés
DE69901813T3 (de) 1998-02-23 2008-08-28 Glaxo Group Ltd., Greenford Unter Druck gesetzte Spenderbehälter
US20030183224A1 (en) 2000-03-01 2003-10-02 Hailey Mark Andrew Metered dose inhaler
WO2001064275A1 (en) 2000-03-01 2001-09-07 Glaxo Group Limited Metered dose inhaler
EP1263491A2 (en) 2000-03-01 2002-12-11 Glaxo Group Limited Metered dose inhaler
EP1259276A2 (en) 2000-03-01 2002-11-27 Glaxo Group Limited Metered dose inhaler
GB0025092D0 (en) 2000-10-13 2000-11-29 Glaxo Group Ltd Medicament dispenser
SE0004610D0 (sv) 2000-12-13 2000-12-13 Astrazeneca Ab Surface modification process
WO2003006181A1 (en) 2001-07-10 2003-01-23 3M Innovative Properties Company Coated medicinal inhalation devices and components method
GB0122725D0 (en) 2001-09-21 2001-11-14 Glaxo Group Ltd Drug dispensing components
TWI302549B (en) * 2001-10-05 2008-11-01 Shinetsu Chemical Co Perfluoropolyether-modified silane, surface treating agent, and antireflection filter
US6716534B2 (en) * 2001-11-08 2004-04-06 3M Innovative Properties Company Coating composition comprising a fluorochemical polyether silane partial condensate and use thereof
US6861149B2 (en) * 2001-11-27 2005-03-01 3M Innovative Properties Company Compositions for aqueous delivery of self-emulsifying fluorinated alkoxysilanes
CN1181081C (zh) * 2003-05-28 2004-12-22 中国科学院上海有机化学研究所 含氟混合环硅氧烷、制备方法及其用途
US7553514B2 (en) * 2006-08-28 2009-06-30 3M Innovative Properties Company Antireflective article
US7891636B2 (en) * 2007-08-27 2011-02-22 3M Innovative Properties Company Silicone mold and use thereof
GB0721739D0 (en) * 2007-11-06 2007-12-19 3M Innovative Properties Co medicinal inhalation devices and components thereof
WO2009061891A2 (en) * 2007-11-06 2009-05-14 3M Innovative Properties Company Medicinal inhalation devices and components thereof

Also Published As

Publication number Publication date
AU2010245839B2 (en) 2014-01-16
EP2427278A1 (en) 2012-03-14
AU2010245839A1 (en) 2011-11-24
EP2427278B1 (en) 2015-09-23
WO2010129758A1 (en) 2010-11-11
US20120097159A1 (en) 2012-04-26
CA2760808A1 (en) 2010-11-11
CN102458690B (zh) 2014-08-13
CN102458690A (zh) 2012-05-16

Similar Documents

Publication Publication Date Title
BRPI1007653A2 (pt) "dispositivos para inalação de insumos medicinais e componentes dos mesmos"
IL222132B (en) Use of cannabidivarin for the preparation of medicaments for treating epilepsy or epileptic seizures
BRPI1007675A2 (pt) "dispositivo para inalação de insumos medicinais"
BR112012018947A2 (pt) composição farmacêutica para tratamento e\ou prevenção do cancêr
IL236221A (en) History of theophyridone and pharmacological preparations containing them for the treatment of diseases
HUE040307T2 (hu) Új oxintomodulin-származékok és azokat tartalmazó gyógyszerészeti készítmények elhízás kezelésére
BRPI1013640A2 (pt) composicao farmaceutica, metodos para o tratamento e usos dos mesmos
EP2132133A4 (en) RELEASE OF PARTICULATE ACTIVE SUBSTANCES
BRPI0920658A2 (pt) dispositivo de inalação e método de dispensar medicamento
PT3111927T (pt) Composições para administração respiratória de agentes ativos e métodos e sistemas associados
PL2464342T3 (pl) Formulacje farmaceutyczne do zapobiegania niewłaściwemu użyciu leków medycznych
PT2355851T (pt) Novos lípidos e composições para a administração de agentes terapêuticos
IL224544B (en) Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
BRPI0807544A2 (pt) Sólido farmacêutico e dose de vacina
DK3064579T3 (da) Farmaceutiske sammensætninger og medicinske anvendelsesformer af konstruerede humane arginaser
FI20135146L (fi) Farmaseuttiset koostumukset ja hoitomenetelmät
BRPI1015124A2 (pt) compostos aromáticos substituídos e usos farmacêuticos dos mesmos
PT2236149E (pt) Composição medicinal para o tratamento de doenças infeciosas respiratórias
GB2548034B (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
BRPI1006040A2 (pt) uso de composições farmacêuticas, tipo de curativo médico, e, tipo de caixa de medicamento
BRPI0918206A2 (pt) derivados de animoéster e composição medicinal destes
PL2582366T3 (pl) Kombinacja farmaceutyczna do leczenia bólu
BRPI1009781A2 (pt) compostos para o tratamento de distúrbios metabólicos, composição farmacêutica que os compreende e uso dos mesmos
BR112012002265A2 (pt) composições farmacêuticas para o tratamento de câncer e outras doenças ou distúrbios
BR112012000303A2 (pt) antagonistas da via hedgehog e aplicações terapêuticas dos mesmos

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.